Literature DB >> 7299344

Expression of an idiotype (Id-460) during in vivo anti-dinitrophenyl antibody responses. III. Detection of Id-460 in normal serum that does not bind dinitrophenyl.

E A Dzierzak, C A Janeway.   

Abstract

Using an anti-idiotypic antibody previously characterized as specific for the hapten binding site of the 2,4-dinitrophenyl (DNP)-binding BALB/c myeloma protein MOPC-460, we have detected substantial amounts of this idiotype (Id-460) in the serum of normal mice. Whereas the idiotypic material in DNP-immune serum binds to DNP, the Id-460-positive material in normal mouse serum is not specific for DNP. The material in normal serum appears to be immunoglobulin. Furthermore, Id-460-positive, non-DNP-binding monoclonal immunoglobulins that completely inhibit our assay for Id-460 are repeatedly isolated when hybridomas are prepared from LPS-activated normal spleen cells. These data are interpreted in the context of Jerne's network hypothesis. It is our conclusion that the non-DNP-binding form of Id-460 is the inherited form and that this form establishes an idiotypic network favoring the production of anti-DNP bearing Id-460. Thus, the paradox of finding an inherited idiotype in the antibody response to the nonpathogen DNP may be resolved by proposing that the true form of Id-460 is specific for an environmental pathogen and that Id-460 dominance in the anti-DNP response is simply a consequence of idiotype-specific regulatory events preconditioned by Id-460-bearing immunoglobulin specific for antigenic determinants unrelated to DNP.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7299344      PMCID: PMC2186524          DOI: 10.1084/jem.154.5.1442

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  Cell-mediated cytotoxicity to trinitrophenyl-modified syngeneic lymphocytes.

Authors:  G M Shearer
Journal:  Eur J Immunol       Date:  1974-08       Impact factor: 5.532

Review 2.  Heavy chain isotype suppression: a review of the immunosuppressive effects of heterologous anti-Ig heavy chain antisera.

Authors:  D D Manning
Journal:  J Reticuloendothel Soc       Date:  1975-07

Review 3.  Studies of structure and immunosuppression of cross-reactive idiotype in strain A mice.

Authors:  A Nisonoff; S T Ju; F L Owen
Journal:  Immunol Rev       Date:  1977       Impact factor: 12.988

4.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

5.  Cellular cooperation during in vivo anti-hapten antibody responses. III. The helper cell activity of activated thymocytes, of spleen cells treated with anti-theta serum, and of spleen cells from anti-thymocyte serum-treated or adult thymectomized donors.

Authors:  C A Janeway
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

6.  Cellular cooperation during in vivo anti-hapten antibody responses. I. The effect of cell number on the response.

Authors:  C A Janeway
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

7.  Genetics of a new IgVH (T15 idiotype) marker in the mouse regulating natural antibody to phosphorylcholine.

Authors:  R Lieberman; M Potter; E B Mushinski; W Humphrey; S Rudikoff
Journal:  J Exp Med       Date:  1974-04-01       Impact factor: 14.307

8.  Quantitative investigations of idiotypic antibodies. IV. Inhibition by specific haptens of the reaction of anti-hapten antibody with its anti-idiotypic antibody.

Authors:  B W Brient; A Nisonoff
Journal:  J Exp Med       Date:  1970-11       Impact factor: 14.307

9.  Expression of an idiotype (Id-460) during in vivo anti-dinitrophenyl antibody responses. II. Transient idiotypic dominance.

Authors:  E A Dzierzak; R W Rosenstein; C A Janeway
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

10.  Absolute frequencies of lipopolysaccharide-reactive B cells producing A5A idiotype in unprimed, streptococcal A carbohydrate-primed, anti-A5A idiotype-sensitized and anti-A5A idiotype-suppressed A/J mice.

Authors:  K Eichmann; A Coutinho; F Melchers
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Strange connections in the unspecific parallel set.

Authors:  G K Lewis; P V Hornbeck
Journal:  Surv Immunol Res       Date:  1982

2.  Normal mice express idiotypes related to autoantibody idiotypes of lupus mice.

Authors:  S K Datta; B D Stollar; R S Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

3.  ABPC 48 cross-reactive idiotopes in BALB/c mice. Natural and levan-induced expression.

Authors:  P Legrain; G Buttin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

4.  Molecular characterization of antibodies bearing Id-460. II. Molecular basis for Id-460 expression.

Authors:  E A Dzierzak; P Brodeur; T Marion; C A Janeway; A Bothwell
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

5.  Non-dinitrophenyl-binding immunoglobulin that bears a dominant idiotype (Id460) associated with antidinitrophenyl antibody is specific for an antigen on Pasteurella pneumotropica.

Authors:  T N Marion; E A Dzierzak; H S Lee; R L Adams; C A Janeway
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

6.  Idiotype connectance in the immune system. I. Expression of a cross-reactive idiotype on induced anti-p-azophenylarsonate antibodies and on endogenous antibodies not specific for arsonate.

Authors:  P V Hornbeck; G K Lewis
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

7.  Mitogen-reactive B cell subpopulations selectively express different sets of V regions.

Authors:  D Primi; F Mami; C Le Guern; P A Cazenave
Journal:  J Exp Med       Date:  1982-07-01       Impact factor: 14.307

8.  Expression of an idiotype (Id-460) during in vivo anti-dinitrophenyl antibody responses. II. Transient idiotypic dominance.

Authors:  E A Dzierzak; R W Rosenstein; C A Janeway
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.